M&G Plc
Source: SEC Form 13F · as of Mar 2026M&G Plc holds 15 biotech & pharma companies tracked by BioSniper, totaling $159.7M in value as of Mar 2026 (SEC Form 13F).
Companies held
15
Total value held
$159.7M
BioSniper AIPage evidence connected
Prepared research question
What matters most for BeOne Medicines Ltd. (ONC)—catalysts, financial risk and supporting evidence?
Run cited research
Traceable citations · Unknowns marked
| Company | Shares | Value |
|---|---|---|
| ONCBeOne Medicines Ltd. | 138,163 | $41.0M |
| INSMINSMED Inc | 98,221 | $16.1M |
| AXSMAxsome Therapeutics, Inc. | 91,339 | $15.4M |
| GILDGILEAD SCIENCES, INC. | 95,757 | $13.3M |
| BMRNBIOMARIN PHARMACEUTICAL INC | 226,541 | $12.7M |
| ALNYALNYLAM PHARMACEUTICALS, INC. | 37,656 | $12.5M |
| RYTMRHYTHM PHARMACEUTICALS, INC. | 138,567 | $12.1M |
| ARQTArcutis Biotherapeutics, Inc. | 469,082 | $11.3M |
| RVMDREVOLUTION MEDICINES, INC. | 74,733 | $7.2M |
| OGNOrganon & Co. | 1,003,250 | $6.0M |
| BRNSBarinthus Biotherapeutics plc. | 5,197,349 | $5.2M |
| HCMHUTCHMED (China) Limited | 255,468 | $3.8M |
| BBIOBridgeBio Pharma, Inc. | 15,041 | $1.1M |
| IONSIONIS PHARMACEUTICALS INC | 14,423 | $1.1M |
| MESOMesoblast Limited | 59,100 | $887K |
13F holdings reflect long positions in U.S.-listed securities as reported to the SEC. Values are point-in-time for the most recent reported quarter.